Tecogen INC

Market Movers (8-K)

AMEX
Tecogen Inc. announced equity awards and salary increases for its CEO and named executive officers, effective June 26, 2026, aimed at aligning executive interests with stockholders.
AMEX
Tecogen Inc. announced the results of its 2026 Annual Meeting, where stockholders re-elected seven directors and approved executive compensation and auditor appointments.
AMEX
Tecogen Inc. reported a significant increase in net loss and a decrease in revenue for Q1 2026, but highlighted an imminent 1 MW chiller system purchase order from Vertiv and progress in data center opportunities.
Worse than expected
AMEX
Tecogen Inc. has extended its Advisory Agreement with John N. Hatsopoulos through March 31, 2028, following board approval.
AMEX
Tecogen Inc. published a note on its natural gas and hybrid chillers, emphasizing their continued relevance for data center cooling despite evolving chip technologies and design changes.
AMEX
Tecogen Inc. reported increased revenues for Q3 2025 but a wider net loss, driven by higher operating expenses and investments in R&D and service upgrades, while seeing significant traction in the data center market.
Delay expected
Worse than expected
Capital raise

Quarterly Earnings (10-Q)

AMEX
Tecogen Inc. reported a net loss of $2.12 million for the first quarter of 2026, with total revenues decreasing by 12.9% year-over-year, primarily driven by a significant drop in product sales.
Worse than expected
Capital raise
AMEX
Tecogen Inc. reported a significant increase in net loss for the third quarter and first nine months of 2025, despite a substantial rise in product revenues driven by chiller sales and a successful $18.1 million public offering.
Worse than expected
Capital raise
AMEX
Tecogen Inc. reported a 54.3% increase in Q2 2025 revenues, driven by strong product sales, and successfully closed an $18.16 million public offering post-period.
Capital raise
Better than expected
AMEX
Tecogen Inc. saw a revenue increase in Q1 2025 driven by product sales, but the company still reported a net loss due to rising operating expenses.
Capital raise
Worse than expected
AMEX
Tecogen Inc. experienced a decrease in revenue during the third quarter of 2024, primarily due to a factory relocation that impacted production capacity.
Worse than expected
Delay expected
Capital raise
AMEX
Tecogen Inc. experienced a significant decrease in product revenue during the second quarter of 2024 due to a factory relocation, while service and energy production revenues saw increases.
Worse than expected
Delay expected
Capital raise

Annual Reports (10-K)

AMEX
Tecogen Inc. saw product revenue more than double in 2025, driven by chiller sales, but overall net loss widened significantly to $8.25 million, impacted by increased operating expenses and goodwill impairment.
Worse than expected
Capital raise
Delay expected
AMEX
Tecogen Inc.'s 2024 10-K filing reveals a year of strategic shifts, supply chain impacts, and facility relocation affecting financial performance, alongside initiatives for future growth in data center cooling and controlled environment agriculture.
Delay expected
Worse than expected
Capital raise
AMEX
Tecogen Inc.'s 2023 annual report highlights a year of strategic shifts, including a focus on controlled environment agriculture and the acquisition of maintenance contracts, amidst a backdrop of fluctuating revenues and increased operating expenses.
Worse than expected
Capital raise

Insider Trading (Form 4)

AMEX
John Kimball Whiting IV, General Counsel & Secretary of TECOGEN INC., reported the acquisition of 19,342 shares of common stock via a Restricted Stock Award.
AMEX
TECOGEN INC. reports that VP of Business Development, Stephen Lafaille, acquired 29,013 shares of common stock on June 26, 2026, under a restricted stock award plan.
AMEX
Roger P. Deschenes, CAO of TECOGEN INC., acquired 29,013 shares of common stock on June 26, 2026, under a restricted stock award plan.
AMEX
TECOGEN INC. reports that COO and President Robert Panora acquired 9,671 shares of common stock and was granted 26,041 stock options.
AMEX
Tecogen Inc. executive Abinand Rangesh reports acquisition of common stock and stock options under incentive plans.
AMEX
Director Susan B. Hirsch of TECOGEN INC. acquired 25,000 stock options with an exercise price of $5.17, vesting over four years.

Proxy Statements (Def-14A)

AMEX
Tecogen Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 5, 2026, to elect directors, ratify auditors, and vote on executive compensation.
AMEX
Tecogen Inc. will hold its 2025 Annual Meeting of Stockholders on June 10, 2025, to elect directors and ratify the appointment of its independent accounting firm.
AMEX
Tecogen Inc. will hold its 2024 Annual Meeting of Stockholders on June 6, 2024, to vote on director elections, auditor ratification, a proposed reverse stock split, and executive compensation.

New Public Companies (S-1)

AMEX
Tecogen Inc. has filed an S-1MEF to register an additional 918,333 shares of common stock, including an over-allotment option for underwriters, to increase the size of its ongoing public offering.
Capital raise
AMEX
Tecogen Inc. filed Amendment No. 3 to its S-1 Registration Statement, primarily to update the signature page with its Principal Accounting Officer and disclose estimated registration expenses, recent share issuance, and corporate governance policies.
Capital raise
Delay expected
AMEX
Tecogen Inc. filed Amendment No. 2 to its S-1 Registration Statement, primarily to include the Principal Accounting Officer on the signature page, update estimated offering expenses, and detail corporate governance policies.
Capital raise
Delay expected
AMEX
Tecogen Inc. filed an Amendment No. 1 to its S-1 Registration Statement, primarily to include its Principal Accounting Officer's signature and update estimated offering expenses, while reiterating its director indemnification policies.
Delay expected
Capital raise
AMEX
Tecogen Inc. has filed an S-1 registration statement to offer 2.67 million shares of common stock, aiming to raise capital for its strategic expansion into the artificial intelligence data center market and other growth initiatives, despite an operating history of losses and identified material weaknesses in internal controls.
Worse than expected
Capital raise
Delay expected

Schedule 13G - Passive Investments

AMEX
Portolan Capital Management and George McCabe have filed a Schedule 13G reporting a 5.19% beneficial ownership stake in Tecogen Inc.
AMEX
Tryfon Natsis and Despoina Pantopoulou disclose a 1.8% beneficial ownership stake in Tecogen Inc. common stock.